Saarinen Antti J, Andras Lindsay, Boachie-Adjei Oheneba, Cahill Patrick, Guillaume Tenner, Snyder Brian, Sponseller Paul, Sturm Peter, Vitale Michael, Helenius Ilkka
Departments of Paediatric Orthopaedic Surgery.
Orthopaedics and Traumatology, University of Turku and Turku University Hospital, Turku.
J Pediatr Orthop. 2025 Sep 1;45(8):492-498. doi: 10.1097/BPO.0000000000002988. Epub 2025 May 5.
Magnetically controlled growing rods (MCGRs) have become the current standard in the growth-friendly treatment of patients with early-onset scoliosis (EOS). MCGRs allow noninvasive lengthenings with external lengthening device and reduce the need for surgical procedures. The association of preoperative body mass index (BMI) and the outcomes of the MCGR treatment is not well known.
Prospectively collected international database was reviewed for EOS patients treated with MCGR. Patients without preoperative BMI data or follow-up <2 years were excluded. Patients were classified as healthy weight, overweight, and underweight using Centers for Disease Control and Prevention (CDC) growth charts. Quality of life was assessed using EOSQ-24. Results were analyzed from the 2-year follow-up.
A total of 663 patients were categorized into underweight (n=91), healthy weight (n=417), and overweight (n=155) groups. There were no significant differences in major curve correction or thoracic height increase among the BMI groups, irrespective of etiology. Distribution of BMI categories differed significantly by etiology ( P =0.009), with lower healthy weight proportions in the syndromic group (92/167, 55%) compared with idiopathic (131/177, 74%) (adjusted P =0.004), and a higher underweight proportion in neuromuscular (36/244, 15%) compared with idiopathic (15/177, 8.5%) (adjusted P =0.044). Higher BMI z-scores were associated with an increased incidence of complications, including implant-related complications (RR 1.1, 95% CI 1.0-1.3) and implant breakage (RR 1.3, 95% CI 1.1-1.7). Healthy weight and underweight patients experienced lower overall complication rates compared with overweight patients. Implant-related complications were less common in underweight patients compared with overweight patients (RR 0.45, 95% CI 0.20-0.90). Higher BMI z-score was a significant predictor of implant breakage, whereas preoperative major curve, kyphosis, and etiology were not. EOSQ-24 scores did not differ significantly among BMI groups, and changes in scores were comparable across groups during follow-up.
BMI status did not influence curve correction, thoracic height increase, or EOSQ-24 outcomes in early-onset scoliosis patients. However, the higher incidence of implant breakage in overweight patients suggests that elevated BMI should be carefully considered when planning treatment.
Level III.
磁控生长棒(MCGRs)已成为早发性脊柱侧弯(EOS)患者生长友好型治疗的当前标准。磁控生长棒可通过外部延长装置进行非侵入性延长,并减少手术需求。术前体重指数(BMI)与磁控生长棒治疗结果之间的关联尚不清楚。
对前瞻性收集的国际数据库中接受磁控生长棒治疗的EOS患者进行回顾性分析。排除术前无BMI数据或随访时间<2年的患者。使用美国疾病控制与预防中心(CDC)生长图表将患者分为体重正常、超重和体重过轻三类。使用EOSQ-24评估生活质量。对2年随访结果进行分析。
总共663例患者被分为体重过轻组(n = 91)、体重正常组(n = 417)和超重组(n = 155)。无论病因如何,BMI组间在主弯矫正或胸廓高度增加方面均无显著差异。BMI类别分布因病因不同而有显著差异(P = 0.009),综合征组体重正常比例(92/167,55%)低于特发性组(131/177,74%)(校正P = 0.004),神经肌肉型组体重过轻比例(36/244,15%)高于特发性组(15/177,8.5%)(校正P = 0.044)。较高的BMI z评分与并发症发生率增加相关,包括与植入物相关的并发症(RR 1.1,95%CI 1.0 - 1.3)和植入物断裂(RR 1.3,95%CI 1.1 - 1.7)。与超重患者相比,体重正常和体重过轻的患者总体并发症发生率较低。与超重患者相比,体重过轻患者中与植入物相关的并发症较少见(RR 0.45,95%CI 0.20 - 0.90)。较高的BMI z评分是植入物断裂的重要预测因素,而术前主弯、后凸和病因则不是。BMI组间EOSQ-24评分无显著差异,随访期间各组评分变化相当。
BMI状态对早发性脊柱侧弯患者的侧弯矫正、胸廓高度增加或EOSQ-24结果无影响。然而,超重患者中植入物断裂的发生率较高,这表明在制定治疗计划时应仔细考虑BMI升高的因素。
三级。